• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

揭示药物自组装成纳米实体的过程。

Revealing Drug Self-Associations into Nano-Entities.

作者信息

Dlim Marwa M, Shahout Fatma S, Khabir Marwa K, Labonté Patrick P, LaPlante Steven R

机构信息

INRS, Institut Armand-Frappier, Université du Québec, 531, boul. des Prairies, Laval, Québec H7V 1B7, Canada.

出版信息

ACS Omega. 2019 May 23;4(5):8919-8925. doi: 10.1021/acsomega.9b00667. eCollection 2019 May 31.

DOI:10.1021/acsomega.9b00667
PMID:31459979
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6647948/
Abstract

The aqueous properties of the drugs Sorafenib, Lapatinib, Gefitinib, Fulvestrant, and Clofazimine were explored to monitor their tendency to self-associate. A combination of nuclear magnetic resonance, dynamics light scattering, and electron and confocal microscopies found that they tended to form large nano-entities having distinct types and sizes and were capable of entering cells. The combination of strategies employed serves to detect and reveal nano-entities along with their three-state equilibria and behaviors in buffers, media, and cells.

摘要

研究了索拉非尼、拉帕替尼、吉非替尼、氟维司群和氯法齐明等药物的水性性质,以监测它们的自缔合倾向。核磁共振、动态光散射以及电子显微镜和共聚焦显微镜相结合的方法发现,它们倾向于形成具有不同类型和大小的大型纳米实体,并且能够进入细胞。所采用的多种策略相结合,有助于检测和揭示纳米实体及其在缓冲液、培养基和细胞中的三态平衡与行为。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f475/6647948/1ebbf4a5b8be/ao-2019-00667r_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f475/6647948/364316f14a9d/ao-2019-00667r_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f475/6647948/4231644012c4/ao-2019-00667r_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f475/6647948/38d47c5d4434/ao-2019-00667r_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f475/6647948/8bcb25a1446f/ao-2019-00667r_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f475/6647948/1ebbf4a5b8be/ao-2019-00667r_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f475/6647948/364316f14a9d/ao-2019-00667r_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f475/6647948/4231644012c4/ao-2019-00667r_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f475/6647948/38d47c5d4434/ao-2019-00667r_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f475/6647948/8bcb25a1446f/ao-2019-00667r_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f475/6647948/1ebbf4a5b8be/ao-2019-00667r_0005.jpg

相似文献

1
Revealing Drug Self-Associations into Nano-Entities.揭示药物自组装成纳米实体的过程。
ACS Omega. 2019 May 23;4(5):8919-8925. doi: 10.1021/acsomega.9b00667. eCollection 2019 May 31.
2
Drug Self-Aggregation into Nano-Entities Has the Potential to Induce Immune Responses.药物自组装成纳米实体有可能引发免疫反应。
Mol Pharm. 2023 Aug 7;20(8):4031-4040. doi: 10.1021/acs.molpharmaceut.3c00196. Epub 2023 Jul 8.
3
Probing the free-state solution behavior of drugs and their tendencies to self-aggregate into nano-entities.探究药物的自由态溶液行为及其自组装成纳米实体的趋势。
Nat Protoc. 2021 Nov;16(11):5250-5273. doi: 10.1038/s41596-021-00612-3. Epub 2021 Oct 27.
4
Tyrosine kinase inhibitors gefitinib, lapatinib and sorafenib induce rapid functional alterations in breast cancer cells.酪氨酸激酶抑制剂吉非替尼、拉帕替尼和索拉非尼诱导乳腺癌细胞快速的功能改变。
Curr Cancer Drug Targets. 2010 Jun;10(4):422-31. doi: 10.2174/156800910791208580.
5
Investigation of antitumor effects of sorafenib and lapatinib alone and in combination on MCF-7 breast cancer cells.索拉非尼和拉帕替尼单独及联合应用对MCF-7乳腺癌细胞抗肿瘤作用的研究。
Asian Pac J Cancer Prev. 2014;15(7):3185-9. doi: 10.7314/apjcp.2014.15.7.3185.
6
Phase I pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors.拉帕替尼联合索拉非尼治疗晚期难治性实体瘤患者的 I 期药代动力学和药效学研究。
Eur J Cancer. 2013 Mar;49(5):989-98. doi: 10.1016/j.ejca.2012.10.016. Epub 2012 Nov 9.
7
Role of Biorelevant Dissolution Media in the Selection of Optimal Salt Forms of Oral Drugs: Maximizing the Gastrointestinal Solubility and in Vitro Activity of the Antimicrobial Molecule, Clofazimine.生物相关溶出介质在口服药物最佳盐型选择中的作用:最大化抗微生物分子氯法齐明的胃肠道溶解度和体外活性
ACS Omega. 2017 Dec 31;2(12):8969-8981. doi: 10.1021/acsomega.7b01454. Epub 2017 Dec 14.
8
pH-dependent self-assembly of polystyrene-block-poly((sulfamate-carboxylate)isoprene) copolymer in aqueous media.聚苯乙烯-嵌段-聚((氨基磺酸酯-羧酸盐)异戊二烯)共聚物在水介质中的pH值依赖性自组装。
Langmuir. 2008 Oct 21;24(20):12017-25. doi: 10.1021/la8025842. Epub 2008 Sep 24.
9
Formulation of Natural Oil Nano-Emulsions for the Topical Delivery of Clofazimine, Artemisone and Decoquinate.天然油纳米乳剂的配方用于氯法齐明、青蒿琥酯和地克珠利的局部递送。
Pharm Res. 2018 Aug 7;35(10):186. doi: 10.1007/s11095-018-2471-9.
10
Poly(N-vinylpyrrolidone)-block-poly(vinyl acetate) as a drug delivery vehicle for hydrophobic drugs.聚(N-乙烯基吡咯烷酮)-嵌段-聚(醋酸乙烯酯)作为疏水性药物的药物传递载体。
Biomacromolecules. 2012 Dec 10;13(12):4109-17. doi: 10.1021/bm301410d. Epub 2012 Nov 14.

引用本文的文献

1
Molecular dynamics simulations as a guide for modulating small molecule aggregation.分子动力学模拟引导小分子聚集态调控。
J Comput Aided Mol Des. 2024 Mar 12;38(1):11. doi: 10.1007/s10822-024-00557-1.
2
Merging Ligand-Based and Structure-Based Methods in Drug Discovery: An Overview of Combined Virtual Screening Approaches.将基于配体和基于结构的方法合并用于药物发现:联合虚拟筛选方法概述。
Molecules. 2020 Oct 15;25(20):4723. doi: 10.3390/molecules25204723.

本文引用的文献

1
Colloidal aggregation: from screening nuisance to formulation nuance.胶体聚集:从筛选干扰到配方微调。
Nano Today. 2018 Apr;19:188-200. doi: 10.1016/j.nantod.2018.02.011. Epub 2018 Mar 10.
2
Multi-parameter optimization of aza-follow-ups to BI 207524, a thumb pocket 1 HCV NS5B polymerase inhibitor. Part 2: Impact of lipophilicity on promiscuity and in vivo toxicity.对拇指口袋型1 HCV NS5B聚合酶抑制剂BI 207524氮杂类似物的多参数优化。第2部分:亲脂性对混杂性和体内毒性的影响。
Bioorg Med Chem Lett. 2015 Mar 1;25(5):1140-5. doi: 10.1016/j.bmcl.2014.12.078. Epub 2015 Jan 3.
3
Lead- and drug-like compounds: the rule-of-five revolution.
类铅化合物和类药物化合物:五规则革命
Drug Discov Today Technol. 2004 Dec;1(4):337-41. doi: 10.1016/j.ddtec.2004.11.007.
4
Colloidal drug formulations can explain "bell-shaped" concentration-response curves.胶态药物制剂可以解释“钟形”浓度-反应曲线。
ACS Chem Biol. 2014 Mar 21;9(3):777-84. doi: 10.1021/cb4007584. Epub 2014 Jan 15.
5
Conformation-based restrictions and scaffold replacements in the design of hepatitis C virus polymerase inhibitors: discovery of deleobuvir (BI 207127).基于构象的限制和支架替换在丙型肝炎病毒聚合酶抑制剂设计中的应用:deleobuvir(BI 207127)的发现。
J Med Chem. 2014 Mar 13;57(5):1845-54. doi: 10.1021/jm4011862. Epub 2013 Nov 11.
6
Monitoring drug self-aggregation and potential for promiscuity in off-target in vitro pharmacology screens by a practical NMR strategy.通过一种实用的 NMR 策略监测药物自聚集和潜在的非靶标体外药理学筛选中的混杂作用。
J Med Chem. 2013 Sep 12;56(17):7073-83. doi: 10.1021/jm4008714. Epub 2013 Aug 22.
7
Compound aggregation in drug discovery: implementing a practical NMR assay for medicinal chemists.化合物聚集在药物发现中的作用:为药物化学家实施一种实用的 NMR 分析方法。
J Med Chem. 2013 Jun 27;56(12):5142-50. doi: 10.1021/jm400535b. Epub 2013 Jun 13.
8
Colloidal aggregation affects the efficacy of anticancer drugs in cell culture.胶态聚集会影响细胞培养中抗癌药物的疗效。
ACS Chem Biol. 2012 Aug 17;7(8):1429-35. doi: 10.1021/cb300189b. Epub 2012 Jun 8.
9
Stability of Self-Assembled Polymeric Micelles in Serum.自组装聚合物胶束在血清中的稳定性
Macromolecules. 2011 Aug 9;44(15):6002-6008. doi: 10.1021/ma200675w. Epub 2011 Jul 8.
10
Molecular imaging of intracellular drug-membrane aggregate formation.细胞内药物-膜聚集体形成的分子成像。
Mol Pharm. 2011 Oct 3;8(5):1742-9. doi: 10.1021/mp200101b. Epub 2011 Aug 12.